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ABSTRACT
Twenty-two patients with suspected brucellar
spondylitis were investigated to evaluate the
possible diagnostic role of Sulesomab, a 99mTc-
antigranulocyte antibody Fab¢ fragment. Sensitiv-
ity and specificity were compared with those of
magnetic resonance imaging (MRI). Skeletal
involvement was detected by MRI in 11 cases,
while leukoscintigraphy indicated normal verteb-
ral uptake in seven of these patients, increased
uptake in two patients, and decreased uptake in
two patients. Leukoscintigraphy of the 11 patients
negative by MRI demonstrated increased uptake
in two cases. The sensitivity and specificity of
leukoscintigraphy were 27.2% and 81.1%,
respectively. Based on these results, leukoscintig-
raphy is not indicated for the management of
patients with suspected brucellar spondylitis.
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Brucellosis is an infectious zoonosis endemic to
the Mediterranean basin, the Middle East, and
Central and South America. Brucella spp. are
facultative intracellular bacteria that can multiply
within mononuclear phagocytes of the reticulo-
endothelial system. This fact may explain some of
the clinical manifestations of systemic brucellosis,
such as the propensity for involvement of the
skeletal system [1,2]. Osteoarticular diseases are
the most common complications and have been
described in 10–85% of patients. Spondylitis is the
most important localisation [3], but early diagno-
sis is often difficult for at least three reasons:
equivocal symptoms, such as diffuse arthromyal-
gias (with back pain), are also found frequently in
non-complicated cases of brucellosis; there is a
long latent stage of up to 3 months between the
onset of symptoms and the appearance of radio-
logical changes [4]; and laboratory tests are of
limited value [5].
The purpose of this prospective study was to
evaluate the possible role of Sulesomab, a
99mTc-antigranulocyte antibody Fab¢ fragment
(LeukoScan; Immunomedics Inc., Morris Plains,
NJ, USA) in the diagnosis of brucellar spondylitis.
This radiotracer, because of its capacity to accu-
mulate in infectious foci, has been used success-
fully in the diagnosis of orthopaedic infections
[6–8]. The results obtained were compared with
those from magnetic resonance imaging (MRI).
Thirty-six consecutive patients with brucellosis
were enrolled in the study, of whom 22 with
suspected spondylitis were investigated with
LeukoScan and MRI. Patients were considered
to have brucellosis if at least two of the following
criteria were present: isolation of Brucella spp.
from blood or other tissue; a standard tube
agglutination titre of antibodies to Brucella spp.
of > 1:160; and the presence of clinical signs
compatible with brucellosis (i.e., fever, sweats,
arthralgias, hepatomegaly, splenomegaly and ⁄ or
signs of focal disease). Spondylitis was suspected
if one or more of the following signs and symp-
toms were present: back pain; tenderness in the
paravertebral muscles; pain when pressuring or
percussing the spinous processes of the vertebrae;
radicular symptoms.
MRI investigation was performed by spin-echo
sequences with a short time repetition ⁄ time echo
in the sagittal and axial planes. T1-weighted
images were obtained before and after intraven-
ous administration of gadopentate dimeglumine.
Corresponding author and reprint requests: A. Cascio, AILMI
(Associazione Italiana per la Lotta contro le Malattie Infettive),
c ⁄ o Scuola di Specializzazione in Malattie Infettive, Universita`
di Messina, Via Consolare Valeria n. 1, 98125 Messina, Italy
E-mail: acascio@unime.it
1020 Clinical Microbiology and Infection, Volume 10 Number 11, November 2004
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 1006–1035
T1-weighted images with fat suppression were
obtained for all patients. A diagnosis of spondy-
litis was confirmed by the presence of partial
homogeneous hypointensity on T1-weighted
images and ⁄ or hyperintensity on T2-weighted
images, with or without disk or soft tissue
involvement in vertebral bodies [9]. Informed
consent was obtained from the patients.
LeukoScan investigation was performed 4 and
24 h after administration of 555 MBq of the
radiotracer (99mTc—0.25 mg monoclonal anti-
body; injected within a few minutes of being
prepared) with a dual-headed gamma camera
(Picher Odissey; Picher, Vimercate, Italy)
equipped with a low-energy high-resolution col-
limator, photopeak 140 keV ± 20%. Planar
(acquisition time 600 s) and SPET images (step
and shoot, angular step 3, acquisition time 25 s,
non-circular orbiter) of the regions of interest
were obtained. LeukoScan images were inter-
preted as positive for infection when uptake in the
region of interest exceeded uptake in reference
points or in the presence of photopenia [10].
The sensitivity and specificity of investigation
by LeukoScan were calculated by taking the
results of MRI as the reference. Of the 36 patients
with brucellosis, 22 (61.1%) were suspected of
having spondylitis. MRI of these 22 patients
detected skeletal involvement in 11 cases; other
alterations detected included a paraspinal abscess
in nine patients, a psoas abscess in four patients,
and epidural extension of the disease in ten
patients. Involvement of the intervertebral disk
was observed in ten patients. Leukoscintigraphy
of the 11 patients positive by MRI demonstrated
normal vertebral activity in seven cases, increased
uptake in two cases (both lumbar tract), and
decreased uptake in two cases (one dorsal tract
and one dorsal–lumbar tract). In one of the two
patients with increased antigranulocyte uptake,
this did not correspond with the skeletal involve-
ment demonstrated by MRI. Leukoscintigraphy of
the 11 patients who were negative by MRI demo-
nstrated increased uptake in two cases, while
none of these patients showed decreased uptake.
Considering both hyperactivity and hypoactivity,
the sensitivity and specificity of LeukoScan were
27.2% (95% CI, 6–60.9) and 81.1% (95% CI,
48.2–97.7), respectively, while the negative and
positive predictive values were 52% (95% CI,
27.8–77) and 60% (95% CI, 14.6–94.7), respect-
ively. Table 1 summarises the clinical characteris-
tics of the 36 patients enrolled in the study.
The imaging examinations used most widely
for the diagnosis of brucellar spondylitis are
99mTm-methylene diphosphonate scintigraphy
and MRI, but both have intrinsic methodological
limits. Bone scintigraphy, although very sensitive,
lacks specificity. Thus, the sensitivity and specif-
icity for detection of osteomyelitis range from
Table 1. Characteristics of 25 patients with brucellosis but not spondylitis compared with those of 11 patients with
brucellosis and spondylitis
Characteristic
Patients with spondylitis
(n = 11)
Patients without spondylitis
(n = 25) pa
Mean age, years (range; SD) 61.8 (29–75; 12.7) 48 (21–80; 18.7) 0.035
Males 7 (63.6%) 10 (40%) NS
Living in rural areas 3 (42.8%) 11 (44%) NS
Occupational exposure 1 (9%) 4 (16%) NS
Ingestion of unpasteurised dairy products 11 (100%) 14 (56%) NS
Mean duration of symptoms
before diagnosis, days (range; SD)
105.2 (15–300; 102) 37.5 (3–180; 41.6) 0.007
Mean erythrocyte sedimentation
rate, mm ⁄ h (range; SD)
64.9 (8–124; 35.6) 49.2 (21–80; 29.7) NS
Positive blood cultures 4 ⁄ 5 7 ⁄ 15 0.09
STAT median titre (range; GMT) 800 (0–1600; 691) 400 (100–6400; 408) NS
Fever 10 (90.9%) 25 (100%) NS
Sweats 3 (27.2%) 13 (52%) NS
Arthromyalgias 11 (100%) 18 (72%) 0.058
Headache 2 (18.1%) 0 0.035
Sciatica 5 (45.4%) 1 (4%) 0.004
Back or neck pain 11 (100%) 11 (44%) 0.037
Sacroilitis 0 1 (4%) NS
Peripheral arthritis 1 (9%) 2 (8%) NS
Testicular pain 0 1 (4%) NS
Leukopenia (< 4000 leukocytes ⁄mm3) 1 (9%) 4 (16%) NS
Increase in serum
hepatic transaminases
3 (27.2%) 12 (48%) NS
aThe t-test and Fisher’s exact test were used as appropriate.
GMT, geometric mean titre; NS, not significant; STAT, standard tube agglutination testing.
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69% to 100% and 38% to 94%, respectively [11].
In contrast, although the sensitivity and
specificity of MRI are very high (96% and 92%,
respectively [12,13]), this diagnostic technique has
the major drawbacks of high cost, lack of univer-
sal availability, imaging interference caused by
metal implants, lower resolution of calcified bone
structures and the cortex, and patient claustro-
phobia during testing [13,14].
Imaging with technetium-labelled anti-leuko-
cyte antibodies has high sensitivity and specificity
for the detection of orthopaedic infections, and is
low in cost, non-invasive and rapid [6,13]. Leu-
koScan is used for imaging inflammation in vivo.
However, it has been shown [15] that Sulesomab
does not localise in inflammation, as a result of
binding to circulating granulocytes, and that it is
cleared into inflammation non-specifically via
increased vascular permeability (it may be cleared
after local binding to primed granulocytes or it
can bind to activated, migrated extravascular
granulocytes). In addition, image positivity in
inflammation depends significantly on local
blood-pool expansion [15].
When the area of interest demonstrates
increased uptake relative to reference points,
leukocyte images are usually interpreted as pos-
itive for infection; however, osteomyelitis pre-
senting as an area of photopenia, especially in the
spine, has been described in the literature [16–20].
For this reason, both hyperactivity and photope-
nia were considered as positive in the current
study. However, the results obtained in this series
of patients were unsatisfactory, and LeukoScan
was also negative in a patient where MRI showed
an evident psoas abscess. Thus, in contrast to
what was hoped, LeukoScan was not useful for
the investigation of patients with suspected bru-
cellar spondylitis, and its use for this purpose is
not recommended.
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